Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Experimental antiviral Drug Remdesivir recognized as potential treatment for 2019-nCov

PharmaSourcesFebruary 10, 2020

Tag: gilead , Antiviral Drug , 2019-nCov , Remdesivir

PharmaSources Customer Service